Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
India Gelatine & Chemicals Ltd (531253)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531253 NSE: Chemicals | Small Cap | India Gelatine &Chem Share Price
₹402.15 4.60 (1.16%)
As on 14-Aug'26 16:59
India Gelatine & Chemicals Ltd (531253)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531253 NSE: Chemicals | Small Cap | India Gelatine &Chem Share Price
₹402.15 4.60 (1.16%)
As on 14-Aug'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹285 Cr.
Current Price
₹402.2
52-Week Low / High
₹295 / 418
TTM EPS
₹36.8
TTM Sales
₹176 Cr.
Book Value per Share
₹284.3
P/E Ratio
10.93
In line with its 5-year historical median
Industry PE
49.5
Price to Book (P/B)
1.41
In line with its 5-year historical median
Price to Sales (P/S)
1.62
Higher than its 5-year historical median
EV/EBITDA
7.08
In line with its 5-year historical median
Dividend Yield
1.49%
Profitability Efficiency
Return on Equity (ROE)
13.75%
Outperforms industry median
Return on Capital Employed (ROCE)
17.66%
Outperforms industry median
Return on Assets (ROA)
12.19%
Operating Profit Margin
17.2%
Net Profit Margin
14.78%
Gross Profit Margin
21.9%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-14.47%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
38.14%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
44.34%
Asset Quality
Promoter Holding
69.05%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹195 Cr.
Equity
₹7.1 Cr.
Face Value
₹10
All Time Low / High
₹7.65 / 513.95
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is India Gelatine & Chemicals Ltd a good quality company?
India Gelatine & Chemicals Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does India Gelatine & Chemicals Ltd performance compare with that of its Peers?
Revenue growth of India Gelatine & Chemicals Ltd vs industry peers?
India Gelatine & Chemicals Ltd revenue CAGR is 3.37%, compared to the industry median CAGR of 7.42%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of India Gelatine & Chemicals Ltd?
Promoters hold 69.05% of the India Gelatine & Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of India Gelatine & Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 19.5% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
India Gelatine & Chemicals Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 2.5% | 2.4% | 5.7% | 6.4% | 8.8% | 6.7% | 25.1% | 24.6% | 13.8% | 17.7% | - |
| Value Creation Index ⓘ | -0.8 | -0.8 | -0.6 | -0.6 | -0.4 | -0.5 | 0.8 | 0.8 | 0.0 | 0.3 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 74.4 | 97.8 | 112 | 132 | 144 | 160 | 205 | 206 | 199 | 170 | 176 |
| Sales YoY Gr. | - | 31.4% | 14.6% | 17.8% | 9.1% | 11.1% | 28.4% | 0.3% | -3.6% | -14.5% | - |
| Adj EPS ⓘ | 2.3 | 2.9 | 7.5 | 7.8 | 7.6 | 6.2 | 32.7 | 34.6 | 20.1 | 29.4 | 36.8 |
| YoY Gr. | - | 29.3% | 159.1% | 2.9% | -2.5% | -18.5% | 429.5% | 5.9% | -42% | 46.4% | - |
| BVPS (₹) ⓘ | 132 | 139.1 | 144.2 | 146.9 | 155.2 | 161.7 | 192.3 | 217.2 | 241.8 | 272.9 | 284.3 |
| Adj Net Profit ⓘ | 2.1 | 2.1 | 5.4 | 5.5 | 5.4 | 4.4 | 23.2 | 24.5 | 14.2 | 20.9 | 26 |
| Cash Flow from Ops. ⓘ | -4.3 | 14.7 | 4.9 | 7.5 | 6.1 | 8.9 | 17.9 | 18.4 | 21 | 27.8 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0.6 | 0.4 | 0.3 | 0.2 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 9.6% | 3.4% | -6.1% | -14.5% | ||||
| Adj EPS ⓘ | 33.1% | 31.2% | -3.5% | 46.4% | ||||
| BVPSⓘ | 8.4% | 12% | 12.4% | 12.9% | ||||
| Share Price | 19.5% | 24.2% | 1.4% | 15.6% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1.7 | 1.9 | 5.3 | 5.3 | 5 | 3.9 | 18.5 | 16.9 | 8.8 | 11.4 | 13.2 |
| Op. Profit Mgn % ⓘ | 0.8 | 2.5 | 5 | 6.2 | 6 | 4.8 | 16.3 | 17 | 10.7 | 17.2 | 17.4 |
| Net Profit Mgn % ⓘ | 2.8 | 2.1 | 4.8 | 4.2 | 3.7 | 2.7 | 11.3 | 11.9 | 7.2 | 12.3 | 14.8 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0 | 0 | - |
| Working Cap Days ⓘ | 276 | 169 | 127 | 116 | 116 | 117 | 107 | 114 | 118 | 133 | 126 |
| Cash Conv. Cycle ⓘ | 140 | 102 | 81 | 73 | 73 | 73 | 62 | 72 | 80 | 88 | 109 |
Valuation of India Gelatine &Chem - Standalone
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 74 | 98 | 112 | 132 | 144 | 160 | 205 | 206 | 199 | 170 |
| Operating Expenses ⓘ + | 74 | 96 | 107 | 125 | 135 | 153 | 172 | 171 | 177 | 141 |
| Operating Profit ⓘ | 1 | 2 | 5 | 7 | 8 | 7 | 33 | 35 | 21 | 29 |
| Operating Profit Margin (%) | 0.8% | 1.6% | 4.9% | 5.0% | 5.9% | 4.6% | 16.3% | 17.0% | 10.7% | 17.2% |
| Other Income ⓘ + | 6 | 4 | 4 | 3 | 5 | 4 | 3 | 8 | 8 | 8 |
| Interest ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation ⓘ | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 | 5 |
| Profit Before Tax ⓘ | 3 | 3 | 6 | 6 | 9 | 7 | 32 | 37 | 23 | 33 |
| Tax ⓘ | -0 | 0 | -0 | 1 | 2 | 2 | 8 | 9 | 5 | 8 |
| Profit After Tax | 3 | 2 | 6 | 5 | 7 | 6 | 24 | 28 | 17 | 25 |
| PAT Margin (%) | 4.3% | 2.3% | 5.1% | 4.1% | 4.9% | 3.5% | 11.7% | 13.8% | 8.8% | 14.8% |
| Adjusted EPS (₹) | 3.4 | 3.2 | 8.1 | 7.6 | 10.0 | 7.9 | 33.7 | 40.0 | 24.5 | 35.4 |
| Dividend Payout Ratio (%) | 26.70% | 62.90% | 43.10% | 19.90% | 24.90% | 31.60% | 14.80% | 27.50% | 20.40% | 17% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 124 | 99 | 102 | 104 | 110 | 115 | 136 | 154 | 172 | 194 | |
| Debt + | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 6 | 3 | 1 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 5 | 6 | 3 | 8 | 5 | 8 | 14 | 10 | 5 | 4 | |
| Others Liabilities ⓘ | 12 | 11 | 11 | 11 | 11 | 13 | 22 | 15 | 14 | 18 | |
| Total Liabilities ⓘ | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 217 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 44 | 42 | 42 | 43 | 40 | 41 | 60 | 69 | 68 | 61 | |
| CWIP ⓘ | 1 | 0 | 0 | 0 | 0 | 1 | 4 | 2 | 1 | 20 | |
| Investments ⓘ | 36 | 30 | 30 | 28 | 34 | 33 | 43 | 44 | 55 | 66 | |
| Inventories | 31 | 26 | 25 | 29 | 28 | 29 | 41 | 44 | 36 | 35 | |
| Trade Receivables | 5 | 4 | 5 | 6 | 9 | 12 | 14 | 13 | 12 | 10 | |
| Cash Equivalents | 9 | 3 | 6 | 7 | 6 | 6 | 9 | 6 | 6 | 11 | |
| Others Assets ⓘ | 16 | 9 | 8 | 10 | 9 | 15 | 9 | 8 | 16 | 14 | |
| Total Assets ⓘ | 141 | 115 | 116 | 124 | 127 | 136 | 180 | 184 | 195 | 217 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | -4 | 15 | 5 | 7 | 6 | 9 | 18 | 18 | 21 | 28 |
| Cash Flow From Investing Activity ⓘ + | -27 | -19 | -1 | -3 | -6 | -8 | -21 | -8 | -17 | -23 |
| Cash Flow From Financing Activity ⓘ + | -1 | -1 | -2 | -3 | -1 | -2 | 7 | -13 | -4 | -7 |
| Net Cash Flow ⓘ | -32 | -5 | 2 | 1 | -1 | -1 | 3 | -3 | -0 | -2 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 2.58 | 2.03 | 5.73 | 5.19 | 6.64 | 4.99 | 19.04 | 19.55 | 10.68 | 13.75 |
| ROCE (%) | 2.46 | 2.42 | 5.67 | 6.36 | 8.82 | 6.7 | 25.05 | 24.64 | 13.75 | 17.66 |
| Asset Turnover Ratio | 0.51 | 0.77 | 0.97 | 1.1 | 1.15 | 1.22 | 1.3 | 1.13 | 1.05 | 0.82 |
| PAT to CFO Conversion(x) | -1.33 | 7.5 | 0.83 | 1.4 | 0.86 | 1.5 | 0.75 | 0.64 | 1.24 | 1.12 |
| Working Capital Days | ||||||||||
| Receivable Days | 25.70 | 16.80 | 15.90 | 16.20 | 20 | 23.80 | 22.50 | 23.40 | 22.80 | 23.60 |
| Inventory Days | 132 | 105.90 | 82.70 | 73.90 | 71.70 | 65.10 | 62.60 | 75 | 73.30 | 76.90 |
| Payable Days | 43.70 | 42 | 33.30 | 35.60 | 32 | 30.20 | 47.70 | 49.90 | 28.10 | 23.50 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
India Gelatine & Chemicals Ltd FAQs
The current trading price of India Gelatine &Chem on 14-Aug-2026 16:59 is ₹402.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Aug-2026 the market cap of India Gelatine &Chem stood at ₹285.2 Cr
The latest P/E ratio of India Gelatine &Chem as of 13-Aug-2026 is 10.93.
The latest P/B ratio of India Gelatine &Chem as of 13-Aug-2026 is 1.41.
The 52-week high of India Gelatine &Chem is ₹418.0 and the 52-week low is ₹295.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of India Gelatine &Chem is ₹176 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that India Gelatine & Chemicals Ltd is a average quality company.
The key valuation ratios of India Gelatine & Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of India Gelatine & Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About India Gelatine & Chemicals Ltd
India Gelatine & Chemicals Ltd. (IGC) was incorporated in 1973 and started its production in 1975 with the technical collaboration & know-how from Konica Gelatine Corporation, Japan. The Financial collaboration came from Nichimen Corporation, Japan. The company is engaged in the manufacturing of chemical products.
In the year 1975, the company started its production of Ossein, the raw material for Gelatine, which was exported to Japan. Within two decades, the company expanded & installed modern equipment imported from countries like Japan, Holland, USA, UK & Germany. From the year 1997, the company commenced the manufacture of Gelatine with the continued support of M/s. Konica Gelatine Corporation, Japan. IGCL is listed on both the Bombay Stock Exchange & Ahmedabad Stock Exchange. Befitting true market leader, IGCL recognises the importance of research. The company's future plans are based on the findings of research & development activities.
The pilot plan setup to augment the research & development activities of IGCL continuously tests & develops its upgradation of processes & products. Gelatine, known for centuries for its high nutritional value is a highly versatile product. Compared to all the usual hydrocolloids, Gelatine offers a unique combination of neutral taste, easy digestibility, brilliant clarity & reversible setting capacity.
Gelatine is accepted as a foodstuff & not just as a food additive, this biological product consists almost all 18 amino acids essential for human nutrition.
Product range of the company includes:
- Photographic Gelatine
- Pharmaceutical Gelatine
- Edible Gelatine
- Technical Gelatine.
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
